Abivax names new global heads of marketing, sales and market access in commercial leadership shake-up

Abivax expanded its commercial leadership team with four senior hires as it prepares a potential U.S. launch of obefazimod.

James Berger was named global head of marketing; he previously served as global franchise head for Amgen’s Tezspire and earlier helped launch Takeda’s Entyvio.

Ivan Nuñez-Pacheco was appointed global head of patient services; he was previously senior director at AbbVie Patient Services supporting Humira, Skyrizi and Rinvoq programs.

Heather Dean was hired as global head of sales, accounts and commercial operations; she is a former Eli Lilly and Takeda executive involved in more than a dozen launches.

Jeff Haas was named global head of market access and pricing; he previously served as corporate vice president at Abbott and earlier held market access roles at Abbott and AbbVie.